Citation 77633

ERKEL,G: BECKER,U: ANKE,T: STERNER,O:. (1996). NIDULAL, A NOVEL INDUCER OF DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA CELLS FROM NIDULA CANDIDA.. 49(12)

Citation Details

Title	NIDULAL, A NOVEL INDUCER OF DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA CELLS FROM NIDULA CANDIDA.
Authors	ERKEL,G: BECKER,U: ANKE,T: STERNER,O:
Year	1996
Volume	49
Issue	12

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Nidula candida (NIDULARIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NIDULAL	None
2	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
3	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
4	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	ACTIVE
5	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	ACTIVE
6	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	ACTIVE
7	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
8	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
9	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
10	RNA SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	WEAK ACTIVITY
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NIDULAL	WEAK ACTIVITY
12	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NIDULAL	WEAK ACTIVITY
13	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	NIDULAL	WEAK ACTIVITY
14	MUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULAL	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NIDULOIC ACID	None
16	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULOIC ACID	WEAK ACTIVITY
17	CELL PROLIFERATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULOIC ACID	WEAK ACTIVITY
18	RNA SYNTHESIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	NIDULOIC ACID	WEAK ACTIVITY

Show SPARQL Queries (1)